205 related articles for article (PubMed ID: 30167970)
41. Effect of Honey and Royal Jelly against Cisplatin-Induced Nephrotoxicity in Patients with Cancer.
Osama H; Abdullah A; Gamal B; Emad D; Sayed D; Hussein E; Mahfouz E; Tharwat J; Sayed S; Medhat S; Bahaa T; Abdelrahim MEA
J Am Coll Nutr; 2017 Jul; 36(5):342-346. PubMed ID: 28548561
[TBL] [Abstract][Full Text] [Related]
42. [Feasibility of short volume hydration in patients with lung cancer treated with Cisplatin-containing chemotherapy].
Ohhara Y; Isobe H; Ito K; Fuke S; Kojima T; Saito H; Nishiura Y
Gan To Kagaku Ryoho; 2015 Jan; 42(1):57-61. PubMed ID: 25596680
[TBL] [Abstract][Full Text] [Related]
43. Amelioration of cisplatin-induced nephrotoxicity in rats by triterpenoid saponin of Terminalia arjuna.
Sherif IO
Clin Exp Nephrol; 2015 Aug; 19(4):591-7. PubMed ID: 25389052
[TBL] [Abstract][Full Text] [Related]
44. Hydration with magnesium and mannitol without furosemide prevents the nephrotoxicity induced by cisplatin and pemetrexed in patients with advanced non-small cell lung cancer.
Muraki K; Koyama R; Honma Y; Yagishita S; Shukuya T; Ohashi R; Takahashi F; Kido K; Iwakami S; Sasaki S; Iwase A; Takahashi K
J Thorac Dis; 2012 Dec; 4(6):562-8. PubMed ID: 23205279
[TBL] [Abstract][Full Text] [Related]
45. Nephrotoxicity: Evidence in Patients Receiving Cisplatin Therapy.
Duffy EA; Fitzgerald W; Boyle K; Rohatgi R
Clin J Oncol Nurs; 2018 Apr; 22(2):175-183. PubMed ID: 29547601
[TBL] [Abstract][Full Text] [Related]
46. Incidence of cisplatin-induced nephrotoxicity and associated factors among cancer patients in Indonesia.
Prasaja Y; Sutandyo N; Andrajati R
Asian Pac J Cancer Prev; 2015; 16(3):1117-22. PubMed ID: 25735341
[TBL] [Abstract][Full Text] [Related]
47. Protective Effect of Mannitol on Cisplatin-Induced Nephrotoxicity: A Systematic Review and Meta-Analysis.
Li S; He X; Ruan L; Ye T; Wen Y; Song Z; Hu S; Chen Y; Peng B; Li S
Front Oncol; 2021; 11():804685. PubMed ID: 34976843
[TBL] [Abstract][Full Text] [Related]
48. Urine ratio of neutrophil gelatinase-associated lipocalin to creatinine as a marker for early detection of cisplatin-associated nephrotoxicity.
Shahbazi F; Sadighi S; Dashti-Khavidaki S; Shahi F; Mirzania M
Iran J Kidney Dis; 2015 Jul; 9(4):306-10. PubMed ID: 26174458
[TBL] [Abstract][Full Text] [Related]
49. Celecoxib, a selective cyclooxygenase-2 inhibitor, attenuates renal injury in a rat model of Cisplatin-induced nephrotoxicity.
Suddek GM; El-Kenawi AE; Abdel-Aziz A; El-Kashef HA
Chemotherapy; 2011; 57(4):321-6. PubMed ID: 21893983
[TBL] [Abstract][Full Text] [Related]
50. Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.
Sato K; Watanabe S; Ohtsubo A; Shoji S; Ishikawa D; Tanaka T; Nozaki K; Kondo R; Okajima M; Miura S; Tanaka J; Sakagami T; Koya T; Kagamu H; Yoshizawa H; Narita I
BMC Cancer; 2016 Mar; 16():222. PubMed ID: 26979596
[TBL] [Abstract][Full Text] [Related]
51. Nordihydroguaiaretic acid ameliorates cisplatin induced nephrotoxicity and potentiates its anti-tumor activity in DMBA induced breast cancer in female Sprague-Dawley rats.
Mundhe NA; Kumar P; Ahmed S; Jamdade V; Mundhe S; Lahkar M
Int Immunopharmacol; 2015 Sep; 28(1):634-42. PubMed ID: 26247680
[TBL] [Abstract][Full Text] [Related]
52. [A clinical phase III trial of ulinastatin (MR-20) for nephrotoxicity of cisplatin].
Nishikawa H; Nakabayashi T; Nakai Y; Kurita Y; Fukuoka M; Onoshi T; Ogura T; Sakuma A; Niitani H; Tsubura E
Gan To Kagaku Ryoho; 1998 Jan; 25(1):97-109. PubMed ID: 9464335
[TBL] [Abstract][Full Text] [Related]
53. Lower Blood Pressure-Induced Renal Hypoperfusion Promotes Cisplatin-Induced Nephrotoxicity.
Mizuno T; Hayashi T; Shimabukuro Y; Murase M; Hayashi H; Ishikawa K; Takahashi K; Yuzawa Y; Yamada S; Nagamatsu T
Oncology; 2016; 90(6):313-20. PubMed ID: 27225867
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of the protective effect of Cystone against cisplatin-induced nephrotoxicity in cancer patients, and its influence on cisplatin antitumor activity.
El-Ghiaty MA; Ibrahim OM; Abdou SM; Hussein FZ
Int Urol Nephrol; 2014 Jul; 46(7):1367-73. PubMed ID: 24448757
[TBL] [Abstract][Full Text] [Related]
55. Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
Shahbazi F; Sadighi S; Dashti-Khavidaki S; Shahi F; Mirzania M; Abdollahi A; Ghahremani MH
Phytother Res; 2015 Jul; 29(7):1046-53. PubMed ID: 25857366
[TBL] [Abstract][Full Text] [Related]
56. Hesperidin and rutin, antioxidant citrus flavonoids, attenuate cisplatin-induced nephrotoxicity in rats.
Kamel KM; Abd El-Raouf OM; Metwally SA; Abd El-Latif HA; El-sayed ME
J Biochem Mol Toxicol; 2014 Jul; 28(7):312-9. PubMed ID: 24819883
[TBL] [Abstract][Full Text] [Related]
57. Cumulative prior dose of cisplatin as a cause of the nephrotoxicity of high-dose chemotherapy followed by autologous stem-cell transplantation.
Caglar K; Kinalp C; Arpaci F; Turan M; Saglam K; Ozturk B; Komurcu S; Yavuz I; Yenicesu M; Ozet A; Vural A
Nephrol Dial Transplant; 2002 Nov; 17(11):1931-5. PubMed ID: 12401849
[TBL] [Abstract][Full Text] [Related]
58. [A clinical phase II trial of ulinastatin (MR-20) for nephrotoxicity of cisplatin].
Nishikawa H; Ogura T; Tsubura E
Gan To Kagaku Ryoho; 1998 Jan; 25(1):89-96. PubMed ID: 9464334
[TBL] [Abstract][Full Text] [Related]
59. A short outpatient hydration schedule for cisplatin administration.
Al Bahrani BJ; Moylan EJ; Forouzesh B; Della-Fiorentina SA; Goldrick AJ
Gulf J Oncolog; 2009 Jan; (5):30-6. PubMed ID: 20084783
[TBL] [Abstract][Full Text] [Related]
60. Cisplatin-induced human peripheral blood mononuclear cells' oxidative stress and nephrotoxicity in head and neck cancer patients: the influence of hydrogen peroxide.
Quintanilha JCF; Visacri MB; Sousa VM; Bastos LB; Vaz CO; Guarnieri JPO; Amaral LS; Malaguti C; Lima CSP; Vercesi AE; Moriel P
Mol Cell Biochem; 2018 Mar; 440(1-2):139-145. PubMed ID: 28828710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
